Meta-Analyses Confirm Broad Kidney Protection From SGLT2 Inhibitors
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have rapidly reshaped the management of kidney and cardiovascular disease. Initially developed as glucose-lowering agents for...
MetaAnalyses
